Jiao Q, Huang Y, He J, Xu Y
Pharmaceutics. 2025; 17(2).
PMID: 40006605
PMC: 11859201.
DOI: 10.3390/pharmaceutics17020238.
Tiwari D, Thorat V, Pakale D
Cureus. 2024; 16(11):e74593.
PMID: 39734941
PMC: 11676328.
DOI: 10.7759/cureus.74593.
Breunig S, Quijano J, Donohue C, Henrickson A, Demeler B, Ku H
ACS Chem Biol. 2023; 18(12):2574-2581.
PMID: 37960878
PMC: 10728891.
DOI: 10.1021/acschembio.3c00561.
Rodriguez-Rodriguez I, Campo-Valera M, Rodriguez J, Frisa-Rubio A
Sensors (Basel). 2023; 23(7).
PMID: 37050725
PMC: 10099355.
DOI: 10.3390/s23073665.
Hanif N, Wu H, Xu P, Li Y, Bibi A, Zulfiqar A
Curr Issues Mol Biol. 2022; 44(2):867-888.
PMID: 35723344
PMC: 8929101.
DOI: 10.3390/cimb44020059.
Evaluation of Outcomes Following Hospital-Wide Implementation of a Subcutaneous Insulin Protocol for Diabetic Ketoacidosis.
Rao P, Jiang S, Kipnis P, Patel D, Katsnelson S, Madani S
JAMA Netw Open. 2022; 5(4):e226417.
PMID: 35389497
PMC: 8990349.
DOI: 10.1001/jamanetworkopen.2022.6417.
Ultra-Fast Insulin-Pramlintide Co-Formulation for Improved Glucose Management in Diabetic Rats.
Maikawa C, Chen P, Vuong E, Nguyen L, Mann J, dAquino A
Adv Sci (Weinh). 2021; 8(21):e2101575.
PMID: 34499434
PMC: 8564421.
DOI: 10.1002/advs.202101575.
Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis.
Malerba E, Alessandrini F, Grossi G, Giunti M, Fracassi F
Front Vet Sci. 2020; 7:559008.
PMID: 33195532
PMC: 7596346.
DOI: 10.3389/fvets.2020.559008.
An ultrafast insulin formulation enabled by high-throughput screening of engineered polymeric excipients.
Mann J, Maikawa C, Smith A, Grosskopf A, Baker S, Roth G
Sci Transl Med. 2020; 12(550).
PMID: 32611683
PMC: 7716884.
DOI: 10.1126/scitranslmed.aba6676.
A co-formulation of supramolecularly stabilized insulin and pramlintide enhances mealtime glucagon suppression in diabetic pigs.
Maikawa C, Smith A, Zou L, Roth G, Gale E, Stapleton L
Nat Biomed Eng. 2020; 4(5):507-517.
PMID: 32393892
PMC: 7274092.
DOI: 10.1038/s41551-020-0555-4.
Stable Monomeric Insulin Formulations Enabled by Supramolecular PEGylation of Insulin Analogues.
Maikawa C, Smith A, Zou L, Meis C, Mann J, Webber M
Adv Ther (Weinh). 2020; 3(1).
PMID: 32190729
PMC: 7079736.
DOI: 10.1002/adtp.201900094.
Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic-aromatic interactions.
Rege N, Wickramasinghe N, Tustan A, Phillips N, Yee V, Ismail-Beigi F
J Biol Chem. 2018; 293(28):10895-10910.
PMID: 29880646
PMC: 6052209.
DOI: 10.1074/jbc.RA118.003650.
Cyclic Peptides that Govern Signal Transduction Pathways: From Prokaryotes to Multi-Cellular Organisms.
Mull R, Harrington A, Sanchez L, Tal-Gan Y
Curr Top Med Chem. 2018; 18(7):625-644.
PMID: 29773060
PMC: 6050129.
DOI: 10.2174/1568026618666180518090705.
A Review of Basal-Bolus Therapy Using Insulin Glargine and Insulin Lispro in the Management of Diabetes Mellitus.
Candido R, Wyne K, Romoli E
Diabetes Ther. 2018; 9(3):927-949.
PMID: 29654514
PMC: 5984925.
DOI: 10.1007/s13300-018-0422-4.
Use of lispro insulin for treatment of diabetic ketoacidosis in cats.
Malerba E, Mazzarino M, Baldo F, Corradini S, Carotenuto G, Giunti M
J Feline Med Surg. 2018; 21(2):115-123.
PMID: 29513157
PMC: 10814606.
DOI: 10.1177/1098612X18761696.
Engineering Synthetically Modified Insulin for Glucose-Responsive Diabetes Therapy.
Webber M, Anderson D, Langer R
Expert Rev Endocrinol Metab. 2016; 10(5):483-489.
PMID: 27570535
PMC: 4999256.
DOI: 10.1586/17446651.2015.1071187.
Glucose-responsive insulin activity by covalent modification with aliphatic phenylboronic acid conjugates.
Chou D, Webber M, Tang B, Lin A, Thapa L, Deng D
Proc Natl Acad Sci U S A. 2015; 112(8):2401-6.
PMID: 25675515
PMC: 4345600.
DOI: 10.1073/pnas.1424684112.
Current therapeutic agents and anesthetic considerations for diabetes mellitus.
Kang H
Korean J Anesthesiol. 2012; 63(3):195-202.
PMID: 23060974
PMC: 3460146.
DOI: 10.4097/kjae.2012.63.3.195.
Comparative pharmacokinetics and insulin action for three rapid-acting insulin analogs injected subcutaneously with and without hyaluronidase.
Morrow L, Muchmore D, Hompesch M, Ludington E, Vaughn D
Diabetes Care. 2012; 36(2):273-5.
PMID: 23043164
PMC: 3554283.
DOI: 10.2337/dc12-0808.
New protein footprinting: fast photochemical iodination combined with top-down and bottom-up mass spectrometry.
Chen J, Cui W, Giblin D, Gross M
J Am Soc Mass Spectrom. 2012; 23(8):1306-18.
PMID: 22669760
PMC: 3630512.
DOI: 10.1007/s13361-012-0403-1.
